Li et al. [41] retrospectively analyzed 18F-FDG PET/CT images of 127 patients with gliomas, extracted a series of quantitative features reflecting the heterogeneity of tumor metabolism, and constructed a combined model including clinical and radiomics features to predict IDH mutation status. This evidence concerns the gene IDH2 and glioma.